Achenheim, France

André Zimmermann

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Sanofi-Aventis. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: André Zimmermann. Retrieved from https://idiyas.com/inventor/andré-zimmermann-i57tnhvy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 213(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andre Zimmermann

Introduction

Andre Zimmermann is a notable inventor based in Achenheim, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic potential. Her work has led to advancements in the treatment of various diseases through innovative chemical solutions.

Latest Patents

Zimmermann holds a patent for "Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors." This patent describes a compound corresponding to a general formula where R represents a hydrogen or halogen atom, an NH, NHR, NHCOR, NO, CN, CHNH, and CHNHR. Alternatively, R can represent an optionally substituted phenyl or an optionally substituted heteroaromatic group. This innovative work has the potential to impact cancer treatment significantly.

Career Highlights

Throughout her career, Andre Zimmermann has been associated with Sanofi-Aventis, a leading global biopharmaceutical company. Her role in the company has allowed her to focus on research and development, contributing to the advancement of new therapeutic agents.

Collaborations

Zimmermann has collaborated with esteemed colleagues, including Hugues D'Orchymont and Luc Van Hijfte. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Andre Zimmermann's contributions to the field of medicinal chemistry exemplify the impact of innovative thinking in the development of new therapeutic agents. Her work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…